Company intelligence / Profile preview

Hang Seng

Jiangmen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangdong Hang Seng Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Jiangmen, China, established in 1995. The company specializes in the research, development, and large-scale manufacturing of chemical drugs, antibiotics, and traditional Chinese medicines (TCM). Its commercial portfolio includes a wide range of products targeting cardiovascular health, respiratory conditions, and infectious diseases. Hang Seng Pharmaceutical operates modern, GMP-certified production facilities and is recognized as a key regional player in the Chinese generic drug market. The company provides both active pharmaceutical ingredients (APIs) and finished dosage forms to domestic and international markets.

Therapeutic areas: Infectious DiseasesCardiovascular
Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Beyond the preview

Go deeper on Hang Seng.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hang Seng.

Explore the full profile